Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marcelo Guimaraes

Vascular & Interventional Radiology Charleston, SC Medical Doctor

NPI 1790963684 CMS profile 172606

171 Ashley Ave, Charleston, SC 29425

Open in the dashboard

General payments

$609,445

548 records reported · program years 2019–2025

Research payments

$3,600

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$451,864 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Marcelo Guimaraes of Charleston, SC is reported in the CMS Open Payments database as having received $609,445 across 548 general payments and $3,600 in research payments paid to them. Separately, studies naming them as principal investigator received $451,864 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $137,305 140
2024 General $111,073 78
2023 General $76,699 73
2022 General $99,000 102
2021 General $28,899 37
2020 General $46,234 29
2019 General $110,236 89
2019 Research $3,600 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marcelo Guimaraes
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Marcelo Guimaraes were reported at $137,305. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Marcelo Guimaraes Vascular & Interventional Radiology median Middle half National median
2019 $110,236 $422 $125–$1,555 $163
2020 $46,234 $200 $68–$652 $114
2021 $28,899 $280 $99–$866 $132
2022 $99,000 $433 $137–$1,497 $149
2023 $76,699 $506 $152–$2,019 $160
2024 $111,073 $556 $175–$1,930 $164
2025 $137,305 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Terumo Medical Corporation $500,282 446 payments
  2. Baylis Medical Technologies Inc. $30,369 7 payments
  3. Ge Healthcare $29,871 9 payments
  4. Siemens Medical Solutions USA, Inc. $17,475 22 payments
  5. Guerbet LLC $9,688 2 payments
  6. Medtronic, Inc. $8,947 36 payments
  7. Medtronic Vascular, Inc. $6,081 16 payments
  8. Baylis Medical Company Inc $5,000 1 payment
  9. Bard Peripheral Vascular, Inc. $1,059 3 payments
  10. Vasorum USA Inc. $267 1 payment
  11. Other $407 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $472,139 199 payments
  2. Travel and Lodging $104,497 123 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,800 4 payments
  4. Food and Beverage $13,009 219 payments
  5. Honoraria $6,000 3 payments
Products named General payments · program years 2019–2025
  1. TR BAND Vascular Access $177,285 123 payments
  2. GLIDESHEATH SLENDER $139,086 167 payments
  3. TR Band Vascular Access $91,629 54 payments
  4. Glidesheath $91,610 53 payments
  5. GlideWire Lesion Access $91,498 46 payments
  6. Navicross Vascular Access $91,209 31 payments
  7. Azur CX Detachable $67,342 86 payments
  8. GLIDEWIRE Lesion Access $50,911 63 payments
  9. HydroPearl $46,646 36 payments
  10. NAVICROSS Vascular Access $39,918 39 payments
  11. Other $85,554 115 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Terumo Medical Corporation $3,600 1 payment

Billing to Medicare

Part B · data year 2024 · 149 billing codes

Paid by Medicare

$68,823

Medicare's payments for the services billed

Medicare patients

520

Average age 71

Services billed

2,073

269 women, 251 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Chronic kidney disease 50%
Ischemic heart disease 44%
Diabetes 42%
Heart failure 37%
Depression 33%
Atrial fibrillation 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

549 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record